- Home
- OZK vs RARE Comparison
OZK vs RARE Comparison
Compare OZK & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZK
- RARE
- Stock Information
- Founded
- OZK 1903
- RARE 2010
- Country
- OZK United States
- RARE United States
- Employees
- OZK N/A
- RARE N/A
- Industry
- OZK Major Banks
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- OZK Finance
- RARE Health Care
- Exchange
- OZK Nasdaq
- RARE Nasdaq
- Market Cap
- OZK 5.1B
- RARE 5.2B
- IPO Year
- OZK 1997
- RARE 2014
- Fundamental
- Price
- OZK $50.54
- RARE $40.89
- Analyst Decision
- OZK Hold
- RARE Strong Buy
- Analyst Count
- OZK 10
- RARE 15
- Target Price
- OZK $50.78
- RARE $92.00
- AVG Volume (30 Days)
- OZK 1.5M
- RARE 1.0M
- Earning Date
- OZK 01-16-2025
- RARE 02-13-2025
- Dividend Yield
- OZK 3.21%
- RARE N/A
- EPS Growth
- OZK 4.60
- RARE N/A
- EPS
- OZK 6.14
- RARE N/A
- Revenue
- OZK $1,481,241,000.00
- RARE $522,745,000.00
- Revenue This Year
- OZK N/A
- RARE $26.70
- Revenue Next Year
- OZK $6.52
- RARE $19.02
- P/E Ratio
- OZK $8.21
- RARE N/A
- Revenue Growth
- OZK 8.45
- RARE 27.44
- 52 Week Low
- OZK $37.43
- RARE $37.02
- 52 Week High
- OZK $51.50
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- OZK 71.18
- RARE 40.43
- Support Level
- OZK $41.34
- RARE $39.99
- Resistance Level
- OZK $46.11
- RARE $44.52
- Average True Range (ATR)
- OZK 1.39
- RARE 2.18
- MACD
- OZK 0.81
- RARE -0.03
- Stochastic Oscillator
- OZK 91.00
- RARE 17.75
About OZK Bank OZK
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit and individual retirement accounts to loan services like real estate, consumer, commercial and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking and other related services.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.